Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q43761841 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010715.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q43761841 | ||
| 024 | ‡a 0000-0002-8207-3937 ‡2 orcid | ||
| 024 | ‡a 6508212575 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q43761841 | ||
| 100 | 0 | ‡a Sónia Sá Santos ‡9 ast ‡9 es ‡9 sl | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a Sónia Sá Santos ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Sónia Sá Santos ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model | ||
| 670 | ‡a Author's Cell growth arrest by nucleotides, nucleosides and bases as a tool for improved production of recombinant proteins | ||
| 670 | ‡a Author's Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes | ||
| 670 | ‡a Author's Culturing primary brain astrocytes under a fully controlled environment in a novel bioreactor | ||
| 670 | ‡a Author's Diet-dependent gut microbiota impacts on adult neurogenesis through mitochondrial stress modulation | ||
| 670 | ‡a Author's Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin | ||
| 670 | ‡a Author's Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation. | ||
| 670 | ‡a Author's Extracellular purine and pyrimidine catabolism in cell culture | ||
| 670 | ‡a Author's Improvement of the pharmacological properties of amidated kyotorphin by means of iodination | ||
| 670 | ‡a Author's Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons | ||
| 670 | ‡a Author's Neuropeptide Kyotorphin | ||
| 670 | ‡a Author's Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer's Disease Patients: Potential Diagnostic and Pharmacological Implications. | ||
| 670 | ‡a Author's Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives. | ||
| 670 | ‡a Author's Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs | ||
| 670 | ‡a Author's Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics | ||
| 670 | ‡a Author's The role of glia in neuronal recovery following anoxia: In vitro evidence of neuronal adaptation | ||
| 909 | ‡a (scopus) 6508212575 ‡9 1 | ||
| 909 | ‡a (orcid) 0000000282073937 ‡9 1 | ||
| 919 | ‡a endotheliummediatedactionofanaloguesoftheendogenousneuropeptidekyotorphintyrosilargininemechanisticinsightsfrompermeationandeffectsonmicrocirculation ‡A Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation. ‡9 1 | ||
| 919 | ‡a extracellularpurineandpyrimidinecatabolismincellculture ‡A Extracellular purine and pyrimidine catabolism in cell culture ‡9 1 | ||
| 919 | ‡a improvementofthepharmacologicalpropertiesofamidatedkyotorphinbymeansofiodination ‡A Improvement of the pharmacological properties of amidated kyotorphin by means of iodination ‡9 1 | ||
| 919 | ‡a inhibitorsofthealphaketoglutaratedehydrogenasecomplexalterglucoseandglutamatemetabolismincerebellargranuleneurons ‡A Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons ‡9 1 | ||
| 919 | ‡a neuropeptidekyotorphin ‡A Neuropeptide Kyotorphin ‡9 1 | ||
| 919 | ‡a neuropeptidekyotorphintyrosylargininehasdecreasedlevelsinthecerebrospinalfluidofalzheimersdiseasepatientspotentialdiagnosticandpharmacologicalimplications ‡A Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer's Disease Patients: Potential Diagnostic and Pharmacological Implications. ‡9 1 | ||
| 919 | ‡a pharmacologicalpotentialoftheendogenousdipeptidekyotorphinandselectedderivatives ‡A Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives. ‡9 1 | ||
| 919 | ‡a sideeffectsofanalgesickyotorphinderivativesadvantagesoverclinicalopioiddrugs ‡A Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs ‡9 1 | ||
| 919 | ‡a stirredvesselculturesofratbraincellsaggregatescharacterizationofmajormetabolicpathwaysandcellpopulationdynamics ‡A Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics ‡9 1 | ||
| 919 | ‡a roleofgliainneuronalrecoveryfollowinganoxiainvitroevidenceofneuronaladaptation ‡A The role of glia in neuronal recovery following anoxia: In vitro evidence of neuronal adaptation ‡9 1 | ||
| 919 | ‡a combiningmetabolicfluxanalysistoolsand13cnmrtoestimateintracellularfluxesofculturedastrocytes ‡A Combining metabolic flux analysis tools and 13C NMR to estimate intracellular fluxes of cultured astrocytes ‡9 1 | ||
| 919 | ‡a amidatedandibuprofenconjugatedkyotorphinspromoteneuronalrescueandmemoryrecoveryincerebralhypoperfusiondementiamodel ‡A Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model ‡9 1 | ||
| 919 | ‡a cellgrowtharrestbynucleotidesnucleosidesandbasesasatoolforimprovedproductionofrecombinantproteins ‡A Cell growth arrest by nucleotides, nucleosides and bases as a tool for improved production of recombinant proteins ‡9 1 | ||
| 919 | ‡a culturingprimarybrainastrocytesunderafullycontrolledenvironmentinanovelbioreactor ‡A Culturing primary brain astrocytes under a fully controlled environment in a novel bioreactor ‡9 1 | ||
| 919 | ‡a dietdependentgutmicrobiotaimpactsonadultneurogenesisthroughmitochondrialstressmodulation ‡A Diet-dependent gut microbiota impacts on adult neurogenesis through mitochondrial stress modulation ‡9 1 | ||
| 919 | ‡a endotheliummediatedactionofanaloguesoftheendogenousneuropeptidekyotorphin ‡A Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 996 | ‡2 NKC|kup20030000007471 | ||
| 996 | ‡2 PTBNP|1732452 | ||
| 996 | ‡2 LC|n 2015183207 | ||
| 996 | ‡2 DNB|116324919X | ||
| 996 | ‡2 PTBNP|1268371 | ||
| 996 | ‡2 ISNI|0000000078037728 | ||
| 996 | ‡2 RERO|A023007898 | ||
| 996 | ‡2 PTBNP|1427831 | ||
| 996 | ‡2 PTBNP|1203201 | ||
| 996 | ‡2 ISNI|0000000059216982 | ||
| 996 | ‡2 LC|nb2005005673 | ||
| 996 | ‡2 LC|no2016151791 | ||
| 996 | ‡2 PTBNP|1389288 | ||
| 996 | ‡2 ISNI|0000000073148429 | ||
| 996 | ‡2 ISNI|0000000123791691 | ||
| 996 | ‡2 LC|n 2016054950 | ||
| 996 | ‡2 SUDOC|267891253 | ||
| 996 | ‡2 BLBNB|000286466 | ||
| 996 | ‡2 ISNI|0000000078251636 | ||
| 996 | ‡2 PTBNP|1527052 | ||
| 996 | ‡2 ISNI|0000000028737224 | ||
| 996 | ‡2 BLBNB|000989160 | ||
| 996 | ‡2 LC|no2010067055 | ||
| 996 | ‡2 PTBNP|1697281 | ||
| 996 | ‡2 ISNI|0000000070798135 | ||
| 996 | ‡2 BLBNB|001587774 | ||
| 996 | ‡2 BLBNB|000567824 | ||
| 996 | ‡2 PTBNP|1431742 | ||
| 996 | ‡2 CAOONL|ncf11906935 | ||
| 996 | ‡2 ISNI|0000000095792864 | ||
| 996 | ‡2 BNE|XX1580061 | ||
| 996 | ‡2 BLBNB|001483143 | ||
| 996 | ‡2 PTBNP|1279432 | ||
| 996 | ‡2 LC|n 2022250540 | ||
| 996 | ‡2 PTBNP|1375223 | ||
| 996 | ‡2 LC|n 88629840 | ||
| 996 | ‡2 BLBNB|000394800 | ||
| 996 | ‡2 BNE|XX5473629 | ||
| 996 | ‡2 SUDOC|169557723 | ||
| 996 | ‡2 BLBNB|001346139 | ||
| 996 | ‡2 PTBNP|1695171 | ||
| 996 | ‡2 PTBNP|1478699 | ||
| 996 | ‡2 BLBNB|001547878 | ||
| 996 | ‡2 BLBNB|001444983 | ||
| 996 | ‡2 PTBNP|1245927 | ||
| 996 | ‡2 LC|no2015115499 | ||
| 996 | ‡2 BLBNB|000578879 | ||
| 996 | ‡2 LC|nb2003059098 | ||
| 996 | ‡2 DNB|1057345512 | ||
| 996 | ‡2 ISNI|0000000091728646 | ||
| 996 | ‡2 ISNI|0000000062528864 | ||
| 996 | ‡2 BLBNB|000541263 | ||
| 996 | ‡2 PTBNP|1423746 | ||
| 996 | ‡2 SUDOC|236099892 | ||
| 996 | ‡2 PTBNP|1559412 | ||
| 996 | ‡2 ISNI|0000000069908181 | ||
| 996 | ‡2 ISNI|0000000067982513 | ||
| 996 | ‡2 LC|no2009086461 | ||
| 996 | ‡2 BLBNB|000473591 | ||
| 996 | ‡2 ISNI|0000000428298785 | ||
| 996 | ‡2 SUDOC|123434645 | ||
| 996 | ‡2 LC|n 86806091 | ||
| 996 | ‡2 BLBNB|001117084 | ||
| 996 | ‡2 PTBNP|1563305 | ||
| 996 | ‡2 BNE|XX1499087 | ||
| 996 | ‡2 BNE|XX1058618 | ||
| 996 | ‡2 PTBNP|1015369 | ||
| 996 | ‡2 SUDOC|131309994 | ||
| 996 | ‡2 ISNI|0000000113677334 | ||
| 996 | ‡2 BNF|14520167 | ||
| 996 | ‡2 J9U|987007387621005171 | ||
| 996 | ‡2 BLBNB|000509684 | ||
| 996 | ‡2 BNC|981061102411606706 | ||
| 996 | ‡2 BLBNB|000556480 | ||
| 996 | ‡2 BLBNB|000522553 | ||
| 996 | ‡2 LC|n 2023253865 | ||
| 996 | ‡2 SUDOC|20311678X | ||
| 996 | ‡2 LC|no2007090545 | ||
| 996 | ‡2 PTBNP|1584936 | ||
| 996 | ‡2 BLBNB|000573284 | ||
| 996 | ‡2 BLBNB|000234060 | ||
| 996 | ‡2 BLBNB|001428080 | ||
| 996 | ‡2 SUDOC|070991464 | ||
| 996 | ‡2 ISNI|0000000067789019 | ||
| 996 | ‡2 LC|no2021067476 | ||
| 996 | ‡2 PLWABN|9813300889205606 | ||
| 996 | ‡2 BLBNB|000471847 | ||
| 996 | ‡2 ISNI|0000000068892093 | ||
| 996 | ‡2 DNB|1163297070 | ||
| 996 | ‡2 BLBNB|000542699 | ||
| 996 | ‡2 BLBNB|001469832 | ||
| 996 | ‡2 DNB|1155181484 | ||
| 996 | ‡2 LC|ns2014003422 | ||
| 996 | ‡2 ISNI|0000000070985563 | ||
| 996 | ‡2 LC|n 84200794 | ||
| 996 | ‡2 BLBNB|000321102 | ||
| 996 | ‡2 ISNI|0000000069502405 | ||
| 996 | ‡2 PTBNP|1589577 | ||
| 996 | ‡2 PTBNP|1410319 | ||
| 996 | ‡2 PTBNP|1422090 | ||
| 996 | ‡2 BNE|XX1499358 | ||
| 996 | ‡2 ISNI|0000000113359977 | ||
| 996 | ‡2 BLBNB|000468163 | ||
| 996 | ‡2 BLBNB|000471295 | ||
| 996 | ‡2 BNF|17950807 | ||
| 996 | ‡2 LC|nb2014025175 | ||
| 996 | ‡2 J9U|987010474249805171 | ||
| 996 | ‡2 DNB|1191269051 | ||
| 996 | ‡2 LC|n 2018251868 | ||
| 996 | ‡2 ISNI|0000000069291505 | ||
| 996 | ‡2 ISNI|0000000073255857 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
